PF4 and COVID-19: ADAMTS-13 levels were reduced, with marked inter-individual variation, and the vWf:ADAMTS-13 ratio was increased in convalescent COVID-19 cases, while levels of platelet factor 4 (PF4), a putative protector of vWf, were also elevated in the same population [30].